Cocrystal Pharma Inc — Quarterly Cash Flow (NASDAQ:COCP) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 16.23 M13.46 M10.66 M8.51 M10.45 M Total liabilities 3.53 M3.93 M3.35 M3.17 M2.78 M Total equity 12.7 M9.52 M7.3 M5.33 M7.67 M Total liabilities & shareholders' equities 16.23 M13.46 M10.66 M8.51 M10.45 M Total debt ————— Net debt —————

Notizie

Cocrystal Pharma avanza il candidato farmaco per il norovirus alla fase 1b

Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial

Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB

Phillip Frost acquista azioni di Cocrystal Pharma (COCP) per 18.812 dollari

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812

Cocrystal Pharma raccoglie 1,03 milioni di dollari in posizionamento privato dai direttori

Cocrystal Pharma raises $1.03 million in private placement from directors

Cocrystal Pharma receives $500,000 NIH grant for influenza drug

Cocrystal Pharma chiude un’offerta diretta registrata di 4,7 milioni di dollari

Cocrystal Pharma closes $4.7 million registered direct offering

Cocrystal Pharma raccoglie 4,7 milioni di dollari tramite offerta diretta

Cocrystal Pharma raises $4.7 million in registered direct offering